Immune-Mediated Cytopenias After Hematopoietic Cell Transplantation: Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment StrategiesThomas F. Michniacki, Sung Won Choi, Christen L. Ebens|Current Oncology Reports|2019Cited by 23
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunityTim Bognàr, Imke H. Bartelink, Christopher C. Dvorak et al.|Blood Advances|2024Cited by 13
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without RadiationMarketa Dimitrov, Christen L. Ebens, Svatava Merkle et al.|Transplantation and Cellular Therapy|2024Cited by 5
Radiation Sparing Reduced Intensity Conditioning for Allogeneic Cell Transplantation in Patients with Dyskeratosis Congenita Comparable to Standard of Care: A Phase III Single Institution TrialMarketa Dimitrov, Christen L. Ebens, Svatava Merkle et al.|Blood|2022Cited by 0
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide Expedites Donor-Derived Immune Reconstitution in a Pediatric Severe Aplastic Anemia CohortMarketa Dimitrov, Christen L. Ebens, Svatava Merkle et al.|Blood|2023Cited by 0